Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Goodfellow

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Gynecologic Oncology|January 22, 2014
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variablesAmy S Joehlin-Price, Carmen M Perrino, Julie Stephens, et al.
Gynecologic Oncology|January 29, 2010
FGFR2 mutations are rare across histologic subtypes of ovarian cancerSara A Byron, Michael G Gartside, Candice L Wellens, et al.
International Journal of Cancer|July 13, 2002
MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancersAlison J Whelan, Sheri Babb, David G Mutch, et al.
Gynecologic Oncology|October 28, 2011
Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancerSaketh R Guntupalli, Israel Zighelboim, Nora T Kizer, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Plos One|March 3, 2012
FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological featuresSara A Byron, Michael Gartside, Matthew A Powell, et al.
Gynecologic Oncology|February 18, 2014
Hypermethylation of miR-203 in endometrial carcinomasYi-Wen Huang, Chieh-Ti Kuo, Jo-Hsin Chen, et al.
Gynecologic Oncology|November 21, 2007
Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repairAshley S Case, Israel Zighelboim, David G Mutch, et al.
Genome Medicine|May 6, 2015
Novel APC promoter and exon 1B deletion and allelic silencing in three mutation-negative classic familial adenomatous polyposis familiesYiing Lin, Shin Lin, Melanie D Baxter, et al.
Gynecologic Oncology|November 26, 2015
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group studyRodney P Rocconi, Heather A Lankes, William E Brady, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Gynecologic Oncology|January 22, 2014
Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variablesAmy S Joehlin-Price, Carmen M Perrino, Julie Stephens, et al.
Gynecologic Oncology|January 29, 2010
FGFR2 mutations are rare across histologic subtypes of ovarian cancerSara A Byron, Michael G Gartside, Candice L Wellens, et al.
International Journal of Cancer|July 13, 2002
MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancersAlison J Whelan, Sheri Babb, David G Mutch, et al.
Gynecologic Oncology|October 28, 2011
Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancerSaketh R Guntupalli, Israel Zighelboim, Nora T Kizer, et al.
Gynecologic Oncology|March 10, 2016
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerFloor J Backes, Christopher J Walker, Paul J Goodfellow, et al.
Plos One|March 3, 2012
FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological featuresSara A Byron, Michael Gartside, Matthew A Powell, et al.
Gynecologic Oncology|February 18, 2014
Hypermethylation of miR-203 in endometrial carcinomasYi-Wen Huang, Chieh-Ti Kuo, Jo-Hsin Chen, et al.
Gynecologic Oncology|November 21, 2007
Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repairAshley S Case, Israel Zighelboim, David G Mutch, et al.
Genome Medicine|May 6, 2015
Novel APC promoter and exon 1B deletion and allelic silencing in three mutation-negative classic familial adenomatous polyposis familiesYiing Lin, Shin Lin, Melanie D Baxter, et al.
Gynecologic Oncology|November 26, 2015
The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group studyRodney P Rocconi, Heather A Lankes, William E Brady, et al.
Pageof 12